You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Claims for Patent: 11,617,758

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,617,758

Title:	Emulsion formulations
Abstract:	A SEDDS or SMEDDS or SNEDDS formulation for drug delivery of a lipophilic therapeutic agent, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of the therapeutic agent by formulation with a lipophilic surfactant, a hydrophilic surfactant, one or more solubilizers and, optionally, digestible oils, resulting in higher bioavailability of the therapeutic agent administered to a subject in need of such therapeutic agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters.
Inventor(s):	Om Dhingra, James S. Bernstein
Assignee:	Marius Pharmaceuticals LLC
Application Number:	US16/834,277
Patent Claims:	1. A pharmaceutical composition comprising: a) from 10 to 25% by weight of solubilized testosterone undecanoate; b) from 10 to 37.5% by weight of hydrogenated castor oil ethoxylate; c) from 10 to 60% by weight of lipophilic surfactant selected from the group consisting of octanoic acid, decanoic acid, undecanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, propylene glycol monolaurate, glycerol/glyceryl monolinoleate, glyceryl mono-and dicaprylocaprate, or a combination thereof; d) from 5 to 37.5% by weight of one or more phytosterol esters; and e) 0-10% by weight of dl-alpha-tocopherol, wherein the composition is a self-emulsifying oral formulation. 2. The pharmaceutical composition of claim 1, comprising: a) about 18.2% by weight of solubilized testosterone undecanoate; b) about 15.0% by weight of hydrogenated castor oil ethoxylate; c) about 39.9% by weight of propylene glycol monolaurate; d) about 25.0% by weight of one or more phytosterol esters; and e) about 2.0% by weight of dl-alpha-tocopherol, wherein the composition is a self-emulsifying oral formulation. 3. A method of treating male hypogonadism in a male subject in need thereof, the method comprising administering the pharmaceutical composition of claim 1 to the subject. 4. The pharmaceutical composition of claim 1, comprising 10 to 15% by weight of hydrogenated castor oil ethoxylate. 5. The pharmaceutical composition of claim 1, wherein the lipophilic surfactant is propylene glycol monolaurate. 6. The pharmaceutical composition of claim 1, comprising 10 to 25% by weight of the one or more phytosterol esters. 7. The pharmaceutical composition of claim 1, comprising 0 to 5% by weight of dl-alpha-tocopherol. 8. The pharmaceutical composition of claim 7, comprising from 10 to 15% by weight of hydrogenated castor oil ethoxylate. 9. The pharmaceutical composition of claim 8, comprising from 15 to 55% by weight of propylene glycol monolaurate.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.